Section Arrow
PODD.NASDAQ
- Insulet Corp
Quotes are at least 15-min delayed:2026/04/26 05:01 EDT
Regular Hours
Last
 189.56
-2.65 (-1.38%)
Day High 
190.675 
Prev. Close
192.21 
1-M High
227.98 
Volume 
1.12M 
Bid
186.25
Ask
196.99
Day Low
186.25 
Open
188.85 
1-M Low
189.63 
Market Cap 
13.31B 
Currency 美元 
P/E 55.23 
%Yield -- 
10-SMA 198.3 
20-SMA 202.37 
50-SMA 224.19 
52-W High 354.88 
52-W Low 189.63 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
3.48/8.05
Enterprise Value
14.24B
Balance Sheet
Book Value Per Share
21.88
Cash Flow
Cash Flow Yield
0.04
Income Statement
Total Revenue
2.71B
Operating Revenue Per Share
22.48
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ITOCiTonic Holdings Ltd.0.374+0.0744+24.83%-- 
BSXBoston Scientific Corp62.07-3.62-5.51%33.94PE
ABTAbbott Laboratories91.13-1.35-1.46%24.75PE
EWEdwards Lifesciences Corp84.15+4.43+5.56%45.45PE
PACBPacific Biosciences of California1.56-0.01-0.64%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.